Rikki A Cannioto1, Kirsten B Moysich2. 1. Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. 2. Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Electronic address: Kirsten.moysich@roswellpark.org.
Abstract
UNLABELLED: Despite the publication of two dozen observational epidemiological studies investigating the association between recreational physical activity (RPA) and epithelial ovarian cancer (EOC) risk and survival over the past two decades, taken collectively, data from retrospective and prospective studies are mixed and remain inconclusive. OBJECTIVE: Our primary purpose was to conduct a careful review and summary of the epidemiological literature depicting the association between EOC and RPA in the framework of identifying factors which may be impeding our ability to observe consistent associations in the literature. Secondly, in the backdrop of the more broad scientific evidence regarding the benefits of RPA, we provide a summary of guidelines for practitioners to utilize in the context of exercise prescription for cancer patients, including a discussion of special considerations and contraindications to exercise which are unique to EOC patients and survivors. METHODS: We performed a comprehensive literature search via PubMed to identify epidemiologic investigations focused on the association between RPA and EOC. To be included in the review, studies had to assess RPA independently of occupational or household activities. RESULTS: In total, 26 studies were identified for inclusion. Evidence of a protective effect of RPA relative to EOC risk is more consistent among-case control studies, with the majority of studies demonstrating significant risk reductions between 30 and 60% among the most active women. Among cohort studies, half yielded no significant associations, while the remaining studies provided mixed evidence of an association. CONCLUSIONS: Given the limitations identified in the current body of literature, practitioners should not rely on inconclusive evidence to dissuade women from participating in moderate or vigorous RPA. Rather, emphasis should be placed on the greater body of scientific evidence which has demonstrated that RPA results in a plethora of health benefits that can be achieved in all populations, including those with cancer.
UNLABELLED: Despite the publication of two dozen observational epidemiological studies investigating the association between recreational physical activity (RPA) and epithelial ovarian cancer (EOC) risk and survival over the past two decades, taken collectively, data from retrospective and prospective studies are mixed and remain inconclusive. OBJECTIVE: Our primary purpose was to conduct a careful review and summary of the epidemiological literature depicting the association between EOC and RPA in the framework of identifying factors which may be impeding our ability to observe consistent associations in the literature. Secondly, in the backdrop of the more broad scientific evidence regarding the benefits of RPA, we provide a summary of guidelines for practitioners to utilize in the context of exercise prescription for cancerpatients, including a discussion of special considerations and contraindications to exercise which are unique to EOC patients and survivors. METHODS: We performed a comprehensive literature search via PubMed to identify epidemiologic investigations focused on the association between RPA and EOC. To be included in the review, studies had to assess RPA independently of occupational or household activities. RESULTS: In total, 26 studies were identified for inclusion. Evidence of a protective effect of RPA relative to EOC risk is more consistent among-case control studies, with the majority of studies demonstrating significant risk reductions between 30 and 60% among the most active women. Among cohort studies, half yielded no significant associations, while the remaining studies provided mixed evidence of an association. CONCLUSIONS: Given the limitations identified in the current body of literature, practitioners should not rely on inconclusive evidence to dissuade women from participating in moderate or vigorous RPA. Rather, emphasis should be placed on the greater body of scientific evidence which has demonstrated that RPA results in a plethora of health benefits that can be achieved in all populations, including those with cancer.
Authors: Petra H Lahmann; Christine Friedenreich; Mandy Schulz; Anne E Cust; Annekatrin Lukanova; Rudolf Kaaks; Anne Tjønneland; Nina Føns Johnsen; Kim Overvad; Agnès Fournier; Marie-Christine Boutron-Ruault; Françoise Clavel Chapelon; Heiner Boeing; Jakob Linseisen; Sabine Rohrmann; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Amalia Mattiello; Carlotta Sacerdote; Claudia Agnoli; Rosario Tumino; J Ramón Quirós; Nerea Larrañaga; Antonio T Agudo; Maria-José Sánchez; Göran Berglund; Jonas Manjer; Evelyn M Monninkhof; Petra H M Peeters; H Bas Bueno-de-Mesquita; Anne M May; Naomi Allen; Kay Tee Khaw; Sheila Bingham; Sabina Rinaldi; Pietro Ferrari; Elio Riboli Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-01 Impact factor: 4.254
Authors: Nils Bergenthal; Andrea Will; Fiona Streckmann; Klaus-Dieter Wolkewitz; Ina Monsef; Andreas Engert; Thomas Elter; Nicole Skoetz Journal: Cochrane Database Syst Rev Date: 2014-11-11
Authors: Qian Xiao; Hannah P Yang; Nicolas Wentzensen; Albert Hollenbeck; Charles E Matthews Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-21 Impact factor: 4.254
Authors: Shalini H Moonsammy; Crissa L Guglietti; Daniel Santa Mina; Sarah Ferguson; Jennifer L Kuk; Sara Urowitz; David Wiljer; Paul Ritvo Journal: J Ovarian Res Date: 2013-04-04 Impact factor: 4.234
Authors: Lindsay M Hannan; Michael F Leitzmann; James V Lacey; Lisa H Colbert; Demetrius Albanes; Arthur Schatzkin; Catherine Schairer Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-05 Impact factor: 4.254
Authors: Michael F Leitzmann; Corinna Koebnick; Steven C Moore; Kim N Danforth; Louise A Brinton; Albert R Hollenbeck; Arthur Schatzkin; James V Lacey Journal: Cancer Causes Control Date: 2008-12-31 Impact factor: 2.506
Authors: Melissa J Newton; Sandi C Hayes; Monika Janda; Penelope M Webb; Andreas Obermair; Elizabeth G Eakin; David Wyld; Louisa G Gordon; Vanessa L Beesley Journal: BMC Cancer Date: 2011-09-08 Impact factor: 4.430
Authors: Britton Trabert; Roberta B Ness; Wei-Hsuan Lo-Ciganic; Megan A Murphy; Ellen L Goode; Elizabeth M Poole; Louise A Brinton; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Galina Lurie; Susanne K Kjær; Estrid Hogdall; Allan Jensen; Daniel W Cramer; Kathryn L Terry; Allison Vitonis; Elisa V Bandera; Sara Olson; Melony G King; Urmila Chandran; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste Leigh Pearce; Malcolm C Pike; Andrew Berchuck; Joellen M Schildkraut; Nicolas Wentzensen Journal: J Natl Cancer Inst Date: 2014-02 Impact factor: 11.816
Authors: James Brian Szender; Rikki Cannioto; Nicolas R Gulati; Kristina L Schmitt; Grace Friel; Albina Minlikeeva; Alexis Platek; Emily H Gower; Ryan Nagy; Edgar Khachatryan; Paul C Mayor; Karin A Kasza; Shashikant B Lele; Kunle Odunsi; Kirsten B Moysich Journal: J Low Genit Tract Dis Date: 2016-07 Impact factor: 1.925
Authors: Anthony J Alberg; Patricia G Moorman; Sydnee Crankshaw; Frances Wang; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa Bondy; Kathleen B Cartmell; Michelle L Cote; Marvella E Ford; Ellen Funkhouser; Linda E Kelemen; Edward S Peters; Ann G Schwartz; Katherine Regan Sterba; Paul Terry; Kristin Wallace; Joellen M Schildkraut Journal: Am J Epidemiol Date: 2016-08-03 Impact factor: 4.897
Authors: Alexis J Platek; Rikki A Cannioto; John Lewis Etter; Jae Kim; Janine M Joseph; Nicholas R Gulati; Kristina L Schmitt; Emily Callahan; Edgar Khachatryan; Ryan Nagy; Albina Minlikeeva; J Brian Szender; Anurag K Singh; Iris Danziger; Kirsten B Moysich Journal: Eur Arch Otorhinolaryngol Date: 2017-08-05 Impact factor: 2.503
Authors: Rikki Cannioto; Michael J LaMonte; Harvey A Risch; Chi-Chen Hong; Lara E Sucheston-Campbell; Kevin H Eng; J Brian Szender; Jenny Chang-Claude; Barbara Schmalfeldt; Ruediger Klapdor; Emily Gower; Albina N Minlikeeva; Gary R Zirpoli; Elisa V Bandera; Andrew Berchuck; Daniel Cramer; Jennifer A Doherty; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Marc T Goodman; Estrid Hogdall; Satoyo Hosono; Allan Jensen; Susan Jordan; Susanne K Kjaer; Keitaro Matsuo; Roberta B Ness; Catherine M Olsen; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Mary Anne Rossing; Elizabeth A Szamreta; Pamela J Thompson; Chiu-Chen Tseng; Robert A Vierkant; Penelope M Webb; Nicolas Wentzensen; Kristine G Wicklund; Stacey J Winham; Anna H Wu; Francesmary Modugno; Joellen M Schildkraut; Kathryn L Terry; Linda E Kelemen; Kirsten B Moysich Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-06 Impact factor: 4.254
Authors: Tianyi Huang; A Heather Eliassen; Susan E Hankinson; Olivia I Okereke; Laura D Kubzansky; Molin Wang; Elizabeth M Poole; Jorge E Chavarro; Shelley S Tworoger Journal: Int J Cancer Date: 2015-09-22 Impact factor: 7.396
Authors: Tianyi Wang; Mary K Townsend; A Heather Eliassen; Kathryn L Terry; Mingyang Song; Melinda L Irwin; Shelley S Tworoger Journal: Int J Cancer Date: 2021-05-21 Impact factor: 7.316
Authors: Sarah E Abbott; Fabian Camacho; Lauren C Peres; Anthony J Alberg; Elisa V Bandera; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Bo Qin; Ann G Schwartz; Jill Barnholtz-Sloan; Paul Terry; Joellen M Schildkraut Journal: Cancer Causes Control Date: 2017-11-29 Impact factor: 2.532
Authors: Sarah E Abbott; Elisa V Bandera; Bo Qin; Lauren C Peres; Patricia G Moorman; Jill Barnholtz-Sloan; Ann G Schwartz; Ellen Funkhouser; Edward S Peters; Michele L Cote; Anthony J Alberg; Paul Terry; Melissa Bondy; Lisa E Paddock; Sydnee Crankshaw; Frances Wang; Fabian Camacho; Joellen M Schildkraut Journal: Cancer Med Date: 2016-02-29 Impact factor: 4.452